Chemoinformaics analysis of Stigmasta-5,22-dien-3beta-yl alpha-D-glucopyranoside
| Molecular Weight | 574.843 | nRot | 8 |
| Heavy Atom Molecular Weight | 516.379 | nRig | 27 |
| Exact Molecular Weight | 574.423 | nRing | 5 |
| Solubility: LogS | -5.206 | nHRing | 1 |
| Solubility: LogP | 6.093 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 99 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 41 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 58 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 35 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 101.936 |
| nHD | 4 | BPOL | 61.658 |
| QED | 0.281 |
| Synth | 5.124 |
| Natural Product Likeliness | 2.777 |
| NR-PPAR-gamma | 0.094 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.988 |
| Pgp-sub | 0.919 |
| HIA | 0.312 |
| CACO-2 | -4.767 |
| MDCK | 0.0000205 |
| BBB | 0.011 |
| PPB | 0.86074 |
| VDSS | 1.148 |
| FU | 0.0126114 |
| CYP1A2-inh | 0.014 |
| CYP1A2-sub | 0.391 |
| CYP2c19-inh | 0.014 |
| CYP2c19-sub | 0.783 |
| CYP2c9-inh | 0.11 |
| CYP2c9-sub | 0.041 |
| CYP2d6-inh | 0.017 |
| CYP2d6-sub | 0.181 |
| CYP3a4-inh | 0.523 |
| CYP3a4-sub | 0.522 |
| CL | 1.353 |
| T12 | 0.094 |
| hERG | 0.337 |
| Ames | 0.017 |
| ROA | 0.251 |
| SkinSen | 0.784 |
| Carcinogencity | 0.086 |
| EI | 0.014 |
| Respiratory | 0.957 |
| NR-Aromatase | 0.107 |
| Antiviral | No |
| Prediction | 0.611327 |